2940 Stock Overview
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.97 |
| 52 Week High | CN¥22.59 |
| 52 Week Low | CN¥11.84 |
| Beta | 0.0030 |
| 1 Month Change | 1.08% |
| 3 Month Change | -10.63% |
| 1 Year Change | -21.45% |
| 3 Year Change | 6.90% |
| 5 Year Change | -8.26% |
| Change since IPO | 1.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2940 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 10.4% | 4.9% | 2.1% |
| 1Y | -21.5% | -13.4% | -14.2% |
Return vs Industry: 002940 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 002940 underperformed the CN Market which returned -14.2% over the past year.
Price Volatility
| 2940 volatility | |
|---|---|
| 2940 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002940 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002940's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 981 | Guo Zheng | www.alkpharm.com |
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in Shengzhou, China.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Fundamentals Summary
| 2940 fundamental statistics | |
|---|---|
| Market cap | CN¥3.15b |
| Earnings (TTM) | CN¥152.42m |
| Revenue (TTM) | CN¥1.71b |
20.7x
P/E Ratio1.8x
P/S RatioIs 2940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2940 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.71b |
| Cost of Revenue | CN¥825.68m |
| Gross Profit | CN¥882.26m |
| Other Expenses | CN¥729.84m |
| Earnings | CN¥152.42m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 51.66% |
| Net Profit Margin | 8.92% |
| Debt/Equity Ratio | 26.1% |
How did 2940 perform over the long term?
See historical performance and comparison